Immatics (IMTX) Operating Leases (2019 - 2025)
Immatics' (IMTX) quarterly Operating Leases came in at $15.0 million in Q4 2025, up 5.06% year-on-year from $14.3 million in Q4 2024, and down 5.02% quarter-over-quarter from $15.8 million in Q3 2025.
Immatics (IMTX) Operating Leases (2019 - 2025) Analysis & Trends
Immatics has disclosed Operating Leases across 7 years of filings, most recently posting $15.0 million for Q4 2025.
- Operating Leases for Q4 2025 came in at $15.0 million, up 5.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.0 million (up 5.06% YoY), and the FY2025 annual result was $14.5 million, up 1.98% from the prior year.
- Operating Leases came in at $15.0 million for Q4 2025 at Immatics, down from $15.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $16.1 million in Q1 2025 to a low of $5.2 million in Q3 2021.
- The 5-year median for Operating Leases is $14.1 million (2022), against an average of $12.7 million.
- Across the five-year window, Operating Leases fell 9.22% in 2021 and jumped 169.38% in 2022, its largest moves.
- Immatics' Operating Leases stood at $11.3 million in 2021, then rose by 12.27% to $12.7 million in 2022, then climbed by 8.82% to $13.8 million in 2023, then increased by 3.62% to $14.3 million in 2024, then climbed by 5.06% to $15.0 million in 2025.
- The last three Operating Leases figures came in at $15.0 million (Q4 2025), $15.8 million (Q3 2025), and $16.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.78 Mn |
| Jun 30, 2025 | 15.97 Mn |
| Mar 31, 2025 | 16.14 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 15.33 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 13.77 Mn |
| Sep 30, 2023 | 14.88 Mn |
| Jun 30, 2023 | 15.34 Mn |
| Mar 31, 2023 | 13.43 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Sep 30, 2022 | 13.97 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.70 Mn |
| Mar 31, 2021 | 5.28 Mn |